US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
US6893625B1
(en)
|
1986-10-27 |
2005-05-17 |
Royalty Pharma Finance Trust |
Chimeric antibody with specificity to human B cell surface antigen
|
EP0560410B1
(en)
|
1987-04-27 |
2002-10-02 |
Inverness Medical Switzerland GmbH |
A test device for performing specific binding assays
|
US5120643A
(en)
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
AU2684488A
(en)
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
US5252496A
(en)
|
1989-12-18 |
1993-10-12 |
Princeton Biomeditech Corporation |
Carbon black immunochemical label
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
PT582368E
(pt)
|
1992-05-29 |
2001-05-31 |
Lilly Co Eli |
Derivados de tienobenzodiazepina para o tratamento de doencas de cns
|
US6034078A
(en)
|
1992-05-29 |
2000-03-07 |
Eli Lilly And Company Limited |
Thienobenzodiazepine compounds
|
US5527709A
(en)
|
1992-06-26 |
1996-06-18 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Immunoassays with labeled thyronine hapten analogues
|
US5642870A
(en)
|
1992-08-05 |
1997-07-01 |
Sargis; Ike |
Switch stand
|
US5395933A
(en)
|
1992-08-07 |
1995-03-07 |
Eastman Kodak Company |
Carbamazepine hapten analogues
|
JPH07247271A
(ja)
|
1994-01-21 |
1995-09-26 |
Otsuka Pharmaceut Co Ltd |
3,4−ジヒドロカルボスチリル誘導体
|
EP0804580B1
(en)
*
|
1994-06-10 |
2008-10-08 |
Oklahoma Medical Research Foundation |
Calcium binding recombinant antibody against protein c
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
US5761894A
(en)
|
1996-09-25 |
1998-06-09 |
Magic Circle Corporation |
Grass striping attachment for lawn mowers
|
US6986890B1
(en)
*
|
1996-11-21 |
2006-01-17 |
Kyowa Hakko Kogyo Co., Ltd. |
Anti-human VEGF receptor Flt-1 monoclonal antibody
|
WO1998059233A1
(en)
|
1997-06-23 |
1998-12-30 |
Luminex Corporation |
Interlaced lasers for multiple fluorescence measurement
|
US6830731B1
(en)
|
1998-01-05 |
2004-12-14 |
Biosite, Inc. |
Immunoassay fluorometer
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
US20030143233A1
(en)
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
UA76708C2
(uk)
|
1999-12-08 |
2006-09-15 |
Сінгента Патисипейшонс Аг |
Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду
|
US7163681B2
(en)
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
US6958156B2
(en)
|
2000-12-15 |
2005-10-25 |
Vyrex Corporation |
Isoflavone derivatives
|
KR20040094705A
(ko)
|
2002-02-21 |
2004-11-10 |
듀크 유니버시티 |
자가면역질환에 대한 시약 및 치료 방법
|
JP4625637B2
(ja)
|
2002-02-22 |
2011-02-02 |
シャイア エルエルシー |
活性物質送達系及び活性物質を保護し投与する方法
|
JP4354280B2
(ja)
|
2002-03-01 |
2009-10-28 |
イミューノメディクス、インコーポレイテッド |
Rs7抗体
|
EP1492794B1
(en)
|
2002-03-28 |
2007-12-12 |
Eli Lilly And Company |
Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
|
SE0201738D0
(sv)
|
2002-06-07 |
2002-06-07 |
Aamic Ab |
Micro-fluid structures
|
JP2005538108A
(ja)
|
2002-07-29 |
2005-12-15 |
ポトマック, ファーマ, エルエルシー |
α−2アドレナリン作動性レセプターアンタゴニストと非定型抗精神病薬精神安定薬との抗精神病薬組み合わせ治療および組成物
|
US7384934B2
(en)
|
2002-08-05 |
2008-06-10 |
Eli Lilly And Company |
Piperazine substituted aryl benzodiazepines
|
EP2960251A1
(en)
|
2003-05-09 |
2015-12-30 |
Duke University |
CD20-specific antibodies and methods of employing same
|
BRPI0413595B8
(pt)
|
2003-08-18 |
2021-05-25 |
H Lundbeck As |
sal de malonato, composição farmacêutica, uso de um sal de malonato, e, método de fabricação de um composto
|
WO2005028458A1
(en)
|
2003-09-23 |
2005-03-31 |
Fermion Oy |
Preparation of quetiapine
|
KR20140015122A
(ko)
|
2003-10-01 |
2014-02-06 |
아돌로 코포레이션 |
스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법
|
WO2005059547A2
(en)
|
2003-12-12 |
2005-06-30 |
Inverness Medical Switzerland Gmbh |
Assay
|
SE0400662D0
(sv)
|
2004-03-24 |
2004-03-24 |
Aamic Ab |
Assay device and method
|
JP4943144B2
(ja)
|
2004-04-26 |
2012-05-30 |
松山 隆美 |
葉酸リセプターベータ(FR−β)に対する単クローン抗体を含有する治療薬
|
SE527036C2
(sv)
|
2004-06-02 |
2005-12-13 |
Aamic Ab |
Analysanordning med reglerat flöde och motsvarande förfarande
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
US7658991B2
(en)
*
|
2004-10-21 |
2010-02-09 |
University Of Georgia Research Foundation, Inc. |
Structures having aligned nanorods and methods of making
|
US7837726B2
(en)
*
|
2005-03-14 |
2010-11-23 |
Abbott Laboratories |
Visible endoprosthesis
|
US20070255094A1
(en)
*
|
2005-03-14 |
2007-11-01 |
Oepen Randolf V |
Crack/fatigue resistant endoprosthesis
|
US20060235005A1
(en)
*
|
2005-04-14 |
2006-10-19 |
Oak Labs, Corp. |
Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
|
ZA200708857B
(en)
*
|
2005-04-22 |
2009-01-28 |
Genentech Inc |
Method for treating dementia or alzheimer's disease with a CD30 antibody
|
SE529254C2
(sv)
|
2005-06-17 |
2007-06-12 |
Aamic Ab |
Optiskt testsystem
|
SE528233C2
(sv)
|
2005-06-20 |
2006-09-26 |
Aamic Ab |
Metod och medel för att åstadkomma vätsketransport
|
EP2279727A3
(en)
|
2005-09-15 |
2011-10-05 |
Elan Pharma International Limited |
Nanoparticulate aripiprazole formulations
|
SE529711C2
(sv)
|
2006-03-22 |
2007-11-06 |
Aamic Ab |
Fluorescensläsare
|
US8975374B2
(en)
|
2006-10-20 |
2015-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
|
CA2672972C
(en)
*
|
2006-12-29 |
2015-06-23 |
Abbott Laboratories |
Diagnostic test for the detection of a molecule or drug in whole blood
|
EP2198309A1
(en)
|
2007-09-27 |
2010-06-23 |
Novartis Ag |
Drug monitoring assay
|
US8133743B2
(en)
|
2007-10-19 |
2012-03-13 |
Roche Diagnostics Operations, Inc. |
Phenobarbital derivatives useful in immunoassay
|
EP3338796A1
(en)
|
2008-07-21 |
2018-06-27 |
Probiodrug AG |
Diagnostic antibody assay
|
AU2009279372A1
(en)
|
2008-08-06 |
2010-02-11 |
Gosforth Centre (Holdings) Pty Ltd |
Compositions and methods for treating psychiatric disorders
|
WO2010033270A1
(en)
|
2008-09-17 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
BRPI0920180B1
(pt)
|
2008-10-14 |
2021-10-26 |
Entasis Therapeutics Limited |
Compostos herecíclicos substituídos, uso dos mesmos e composiçâo farmacêutica compreendendo os ditos compostos
|
CA2742074A1
(en)
|
2008-10-29 |
2010-08-26 |
Janssen Pharmaceutica Nv |
Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene
|
EP2194048A1
(en)
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
US8480333B2
(en)
|
2008-12-26 |
2013-07-09 |
Steven Edward DeMay |
Frame rail assemblies and interlocking frame rail systems
|
EP2700400A1
(en)
|
2009-01-26 |
2014-02-26 |
Egalet Ltd. |
Controlled release formulation with continuous efficacy
|
JP5986382B2
(ja)
|
2009-03-10 |
2016-09-06 |
ベイラー リサーチ インスティテュートBaylor Research Institute |
抗原提示細胞ターゲティング癌ワクチン
|
ES2885698T3
(es)
|
2009-06-25 |
2021-12-15 |
Alkermes Pharma Ireland Ltd |
Profármacos de compuestos nh-ácidos
|
NZ597960A
(en)
|
2009-07-31 |
2013-07-26 |
Ascendis Pharma As |
Biodegradable polyethylene glycol based water-insoluble hydrogels
|
US8076097B2
(en)
|
2009-08-19 |
2011-12-13 |
Saladax Biomedical Inc. |
Imatinib immunoassay
|
WO2011042450A1
(en)
|
2009-10-06 |
2011-04-14 |
Ascendis Pharma As |
Carrier linked paliperidone prodrugs
|
CN102781236B
(zh)
|
2009-12-31 |
2015-01-07 |
凯姆制药公司 |
喹硫平的氨基酸缀合物、其制备和使用方法
|
WO2011112657A1
(en)
|
2010-03-11 |
2011-09-15 |
Kempharm, Inc. |
Fatty acid conjugates of quetiapine, process for making and using the same
|
US8088594B2
(en)
*
|
2010-03-16 |
2012-01-03 |
Saladax Biomedical Inc. |
Risperidone immunoassay
|
CN102260290A
(zh)
|
2010-05-25 |
2011-11-30 |
苏州波锐生物医药科技有限公司 |
喹喏啉酮类化合物及其在制备精神病药物中的用途
|
WO2011159537A2
(en)
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Method and device for analyte detection
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
ES2691671T3
(es)
|
2010-06-24 |
2018-11-28 |
Alkermes Pharma Ireland Limited |
Profármacos de compuestos NH-acídicos: derivados de éster, carbonato, carbamato y fosfonato
|
US9156822B2
(en)
|
2010-07-02 |
2015-10-13 |
The University Of North Carolina At Chapel Hill |
Functionally selective ligands of dopamine D2 receptors
|
US8623324B2
(en)
|
2010-07-21 |
2014-01-07 |
Aat Bioquest Inc. |
Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
|
WO2013024048A1
(en)
|
2011-08-12 |
2013-02-21 |
Ascendis Pharma A/S |
Polymeric hyperbranched carrier-linked prodrugs
|
CA2843875C
(en)
|
2011-08-12 |
2020-01-07 |
Ascendis Pharma A/S |
High-loading water-soluble carrier-linked prodrugs
|
ES2715562T3
(es)
|
2011-12-15 |
2019-06-04 |
Alkermes Pharma Ireland Ltd |
Profármacos de compuestos de amina secundaria
|
JP6262732B2
(ja)
|
2012-08-16 |
2018-01-17 |
ヤンセン ファーマシューティカ エヌ.ベー. |
N型カルシウムチャネル遮断剤としての置換ピラゾール
|
AU2013305938B2
(en)
|
2012-08-21 |
2017-08-17 |
Saladax Biomedical Inc. |
Antibodies to paliperidone haptens and use thereof
|
EP2888285B1
(en)
|
2012-08-21 |
2024-04-17 |
Janssen Pharmaceutica NV |
Antibodies to aripiprazole haptens and use thereof
|
CN110054693A
(zh)
|
2012-08-21 |
2019-07-26 |
詹森药业有限公司 |
喹硫平半抗原的抗体及其用途
|
US9410972B2
(en)
|
2012-08-21 |
2016-08-09 |
Janssen Pharmaceutica Nv |
Antibodies to quetiapine and use thereof
|
US9304126B2
(en)
|
2012-08-21 |
2016-04-05 |
Janssen Pharmaceutica Nv |
Haptens of quetiapine
|
EP3492473A1
(en)
|
2012-08-21 |
2019-06-05 |
Janssen Pharmaceutica NV |
Haptens of olanzipine
|
US9394354B2
(en)
|
2012-08-21 |
2016-07-19 |
Janssen Pharmaceutica Nv |
Haptens of paliperidone
|
CN104822660A
(zh)
|
2012-08-21 |
2015-08-05 |
詹森药业有限公司 |
阿立哌唑半抗原及其在免疫测定中的应用
|
CN104736561B
(zh)
|
2012-08-21 |
2018-06-12 |
詹森药业有限公司 |
帕潘立酮的抗体及其用途
|
ES2666000T3
(es)
|
2012-08-21 |
2018-04-30 |
Janssen Pharmaceutica, N.V. |
Anticuerpos para aripiprazol y uso de los mismos
|
AU2013305901B2
(en)
|
2012-08-21 |
2017-10-26 |
Saladax Biomedical Inc. |
Antibodies to olanzapine and use thereof
|
CA2882595C
(en)
|
2012-08-21 |
2019-06-04 |
Ortho-Clinical Diagnostics, Inc. |
Antibodies to olanzapine haptens and use thereof
|
CA2882560C
(en)
|
2012-08-21 |
2020-10-27 |
Ortho-Clinical Diagnostics, Inc. |
Haptens of risperidone and paliperidone for use in immunoassays
|
EP2888284B1
(en)
|
2012-08-21 |
2022-07-06 |
Janssen Pharmaceutica NV |
Antibodies to risperidone haptens and use thereof
|
ES2691092T3
(es)
|
2012-08-21 |
2018-11-23 |
Janssen Pharmaceutica Nv |
Anticuerpos contra la risperidona y uso de los mismos
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|